← Leaderboards
Qi Wen Fan
University Of California, San Francisco
$1,414,584
Attributed
$4,243,752
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $671.2K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,243,752 · 2
By mechanism
R01$4,243,752 · 2
Top collaborators
- Kevan M. Shokat7 shared
- William A Weiss7 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Neil P Shah$6,146,823
- Hong-Yu Li$3,813,256
- William A Weiss$31,543,847
- Steven William Hetts$9,446,453
- James A Wells$24,064,501
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsPhosphotransferasesGlioblastomaLinkMolecular ChaperonesPharmacologyDrug KineticsFrap1 GeneIn VivoLigandsMedicineAutomobile DrivingNeoplastic CellPathway InteractionsBrainBrain NeoplasmsFeedbackCell LineCellsGliomaBindingClinical TrialsBinding SitesPre-Clinical
Grant awards (7)
Brain-Restricted Kinase Inhibition with Binary Pharmacology$663,348
R01 · FY2025 · CA
Brain-Restricted Kinase Inhibition with Binary Pharmacology$671,177
R01 · FY2024 · CA
Improving the efficacy of mTOR inhibition$578,475
R01 · FY2022 · CA
Improving the efficacy of mTOR inhibition$590,279
R01 · FY2021 · CA
Improving the efficacy of mTOR inhibition$588,452
R01 · FY2020 · CA
Improving the efficacy of mTOR inhibition$568,138
R01 · FY2019 · CA
Improving the efficacy of mTOR inhibition$583,883
R01 · FY2018 · CA